Loại tài liệu:    Chỉ tìm trong: 
Tìm được 19 kết quả
Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort
Tác giả: Tommaso Guerra, Francesca Caputo, Antonella Bianco, Damiano Paolicelli, Pietro Iaffaldano
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc: 
 
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from
Tác giả: Bruno Fautrel, Yoram Bouhnik, Salima Hateb, Janet Addison, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  949.5074
 
Effectiveness and Safety of Vildagliptin Sustained Release in the Management of Type 2 Diabetes Mellitus: Real-World Evidence in Indian Patients [NOVELTY Study]
Tác giả: Rakesh Sahay, Anil Bhansali, Surendra Kumar Sharma, Rahul Iyer, Amarnath Sugumaran, Senthilnathan Mohanasundaram, Jaideep Gogtay
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  616.462
 
Lipid-Lowering Efficiency and Safety of Alirocumab 300 mg Using a 2-mL Autoinjector Device in Real-World Practice: The MARS Study
Tác giả: Klaus G Parhofer, Peter Bramlage, Constanze Gries, Cornelia Harder, Christiane Look, W Dieter Paar, Ursula Rauch-Kröhnert
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  523.43
 
Association Between Inappropriate Prescribing According to the 2023 Beers Criteria and Different Health Outcomes: A 1-Year Longitudinal Study in Community-Dwelling Older Adults
Tác giả: Rosiane Mendes da Silva, Alessandra Lamas Granero Lucchetti, Maria Eduarda Corradi Ferreira, Leonardo Oliveira Silva, Oscarina da Silva Ezequiel, Eduardo Luiz Mendonça Martins, Giancarlo Lucchetti
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  305.24
 
Correction: Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen i...
Tác giả: Yuka Obayashi, Shoichiro Hirata, Seiji Kawano, Yoshiro Kawahara, Motoyuki Otsuka, Yoshiyasu Kono, Makoto Abe, Koji Miyahara, Masahiro Nakagawa, Michihiro Ishida, Yasuhiro Choda, Kenta Hamada, Masaya Iwamuro
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  949.5074
 
Effects of the Japanese Kampo Medicines Rikkunshito, Shakuyakukanzoto and Goreisan on Lenvatinib Plasma Concentrations i...
Tác giả: Kazuma Fujita, Akifumi Suzuki, Mitsuji Nagahama, Kiminori Sugino, Chie Masaki, Koichi Ito, Masatomo Miura
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  495.6
 
Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure
Tác giả: Francesco Saverio Mennini, Americo Cicchetti, Paolo Sciattella, Filippo Rumi, Matteo Zanuzzi, Angelica Carletto, Annalisa Sammarco, Federica Romano, Pierluigi Russo
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  615.2—615.3
 
Medication Errors and Error Chains Involving High-Alert Medications in a Paediatric Hospital Setting: A Qualitative Anal...
Tác giả: Sini Kuitunen, Mari Saksa, Anna-Riia Holmström
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  511.43
 
Adverse Reaction Reporting for Naxitamab in Chinese Expanded Access Treatment for Relapsed/Refractory High-Risk Neurobla...
Tác giả: Xiaowen Qian, Dufei Zhang, Xiaowen Zhai, Kai Li, Weiming Chen, Peijun Zhuang, Hongsheng Wang, Zhixian Lei, Yan Li, James Eldridge, Kuiran Dong
Xuất bản: Switzerland: Drugs - real world outcomes , 2025
Bộ sưu tập: NCBI
ddc:  027.625
 
1 2 Tiếp

Truy cập nhanh danh mục